CVS/pharmacy launches new bill pay service for health insurance premiums
WOONSOCKET, R.I. — CVS/pharmacy announced on Monday that it is launching later this spring a new service, dubbed Bill Pay at CVS/pharmacy, to help customers manage their monthly health insurance premiums.
Members of participating health plans can bring their insurance bills to any one of CVS/pharmacy’s 7,600 stores across the United States to pay their premiums at no additional cost. CVS/pharmacy is the first national retail pharmacy to offer this service.
"Millions of Americans have enrolled in health insurance this year for the first time and we want to help with this transition by providing an easy way to pay their premiums in our stores," stated Josh Flum, SVP of retail pharmacy at CVS Caremark. "Providing customers with this level of unprecedented access to manage their insurance premiums is part of our commitment to delivering innovative solutions to help people on their path to better health."
CVS/pharmacy has partnered with InComm to facilitate bill payments at all cash registers in the pharmacy or at front checkout. Members of health plans that participate in Bill Pay at CVS/pharmacy will receive their monthly premium bills featuring a customer-specific barcode and instructions on how it may be used to pay their premium. CVS will scan the barcode and collect the member’s desired payment, which may be made using cash, credit card or debit card.
CVS/pharmacy also accepts insurance bill payments from members of health plans that are enrolled in MoneyGram’s bill payment service. Most CVS/pharmacy locations are equipped with MoneyGram phones or kiosks to facilitate a cash-only bill payment at a store’s front checkout.
Teva’s injunction on introduction of Mylan’s generic Copaxone denied
PITTSBURGH — Mylan on Friday announced that Supreme Court Chief Justice John Roberts has denied Teva’s application for an injunction seeking to prevent Mylan’s launch of a generic version of Copaxone (glatiramer acetate injection) pending the Supreme Court’s decision on Teva’s appeal. This is the second time that the Chief Justice has denied Teva’s request for such an injunction.
In March, the Supreme Court granted Teva’s petition for certiorari seeking clarification of the standard of review that appellate courts should apply when considering appeals relating to the construction of a patent claim. Oral argument is expected to be heard in the fall of 2014.
"We look forward to introducing the first gene treatment for multiple sclerosis patients in the U.S. at market formation," stated Heather Bresch, Mylan CEO. "Mylan remains eligible to receive approval from the U.S. Food and Drug Administration on May 25, 2014."
PAM adds coconut oil spray to the mix
OMAHA, Neb. — PAM Cooking Spray, a ConAgra Foods brand, earlier this week announced the introduction of PAM Coconut Oil Spray to it’s lineup.
The spray is made with 100% coconut oil and is ideal for gluten-free cooking, the company said. PAM also cited an Omnibus survey that indicated high consumer interest in the coconut oil spray.
“We have seen a tremendous rise in the popularity of coconut oil over the past year,” said Brittany Lanier, brand manager for PAM. “The addition of PAM Coconut Oil Spray gives consumers a no-fuss alternative to traditional coconut oils for fat-free cooking, while delivering the superior non-stick performance they’ve come to expect from PAM.”
PAM Coconut Oil Spray is now available at Walmart, with additional retail locations to follow. The product comes in 5-oz. cans for a suggested retail price of $4.29.